Shares of Siemens Healthineers AG (ETR:SHL - Get Free Report) traded up 0.7% during trading on Tuesday . The company traded as high as €46.78 ($54.40) and last traded at €46.55 ($54.13). 750,708 shares changed hands during mid-day trading, The stock had previously closed at €46.23 ($53.76).
Siemens Healthineers Stock Performance
The stock's 50 day moving average price is €46.81 and its 200 day moving average price is €50.29. The company has a current ratio of 1.25, a quick ratio of 0.71 and a debt-to-equity ratio of 89.20. The firm has a market cap of $52.52 billion, a PE ratio of 27.06, a P/E/G ratio of 1.16 and a beta of 0.70.
Siemens Healthineers Company Profile
(
Get Free Report)
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Siemens Healthineers, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Siemens Healthineers wasn't on the list.
While Siemens Healthineers currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
